Physician profile
Tan Li
NPI 1417483918
$1,722.98
in general payments reported to CMS, 2019-2025
20 companies · $648 in 2025
The $648 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $79.04 · 2023: $378 · 2024: $618 · 2025: $648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,624 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,623.72 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $350.46 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $297.21 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $205.54 | 2023-2025 | Breztri, Farxiga, Airsupra |
| Otsuka America Pharmaceutical, INC. | $177.72 | 2023-2025 | Rexulti |
| Glaxosmithkline, LLC. | $131.62 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $69.84 | 2024-2025 | |
| Lilly USA, LLC | $67.91 | 2023-2024 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $51.81 | 2024-2025 | Cologuard Collection Kit |
| Abbvie INC. | $44.28 | 2025 | |
| Viatris Specialty LLC | $43.90 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $41.77 | 2023-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Amgen INC. | $35.99 | 2024 | Repatha, Otezla |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $35.99 | 2023-2024 | Caplyta |
| Mylan Specialty L.P. | $34.96 | 2024 | Yupelri |
| Phadia US INC. | $27.67 | 2023-2025 | Immunocap |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $27.27 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Takeda Pharmaceuticals U.S.A., INC. | $25.48 | 2020 | |
| Astellas Pharma US INC | $21.28 | 2020 | |
| Allergan, INC. | $20.87 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tan Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.